NMR structure of CXCR3 binding chemokine CXCL11 (ITAC)

CXCL11 (ITAC) is one of three chemokines known to bind the receptor CXCR3, the two others being CXCL9 (Mig) and CXCL10 (IP‐10). CXCL11 differs from the other CXCR3 ligands in both the strength and the particularities of its receptor interactions: It has a higher affinity, is a stronger agonist, and behaves differently when critical N‐terminal residues are deleted. The structure of CXCL11 was determined using solution NMR to allow comparison with that of CXCL10 and help elucidate the source of the differences. CXCL11 takes on the canonical chemokine fold but exhibits greater conformational flexibility than has been observed for related chemokines under the same sample conditions. Unlike related chemokines such as IP‐10 and IL‐8, ITAC does not appear to form dimers at millimolar concentrations. The origin for this behavior can be found in the solution structure, which indicates a β‐bulge in β‐strand 1 that distorts the dimerization interface used by other CXC chemokines.

[1]  M. Décorps,et al.  Improvements in solvent-signal suppression , 1992 .

[2]  B. Lindner,et al.  Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I‐TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine , 2002, Journal of leukocyte biology.

[3]  E. Werner,et al.  Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejection , 2001, European journal of immunology.

[4]  T. Williams,et al.  Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi‐step model of ligand binding and receptor activation , 2003, European journal of immunology.

[5]  J. Thornton,et al.  Identification, classification, and analysis of beta‐bulges in proteins , 1993, Protein science : a publication of the Protein Society.

[6]  B. Sykes,et al.  Neutrophil-activating Peptide-2 and Melanoma Growth-stimulatory Activity Are Functional as Monomers for Neutrophil Activation* , 1997, The Journal of Biological Chemistry.

[7]  M. Baggiolini,et al.  The Ligands of CXC Chemokine Receptor 3, I-TAC, Mig, and IP10, Are Natural Antagonists for CCR3* , 2001, The Journal of Biological Chemistry.

[8]  M. Billeter,et al.  MOLMOL: a program for display and analysis of macromolecular structures. , 1996, Journal of molecular graphics.

[9]  James G. Boyd,et al.  Interferon–inducible T Cell Alpha Chemoattractant (I-TAC): A Novel Non-ELR CXC Chemokine with Potent Activity on Activated T Cells through Selective High Affinity Binding to CXCR3 , 1998, The Journal of experimental medicine.

[10]  S. Grzesiek,et al.  Isotope-edited multidimensional NMR of calcineurin B in the presence of the non-deuterated detergent CHAPS , 1993, Journal of biomolecular NMR.

[11]  R. Abseher,et al.  Essential spaces defined by NMR structure ensembles and molecular dynamics simulation show significant overlap , 1998, Proteins.

[12]  N. Guex,et al.  SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.

[13]  J. Morgan,et al.  Physical mapping of the CXC chemokine locus on human chromosome 4 , 1999, Cytogenetic and Genome Research.

[14]  M. Parmentier,et al.  Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. , 2001, Blood.

[15]  B D Sykes,et al.  1H NMR solution structure of an active monomeric interleukin-8. , 1995, Biochemistry.

[16]  B Dewald,et al.  Human chemokines: an update. , 1997, Annual review of immunology.

[17]  D Rojo,et al.  Structural biology of chemokine receptors. , 1999, Biological research.

[18]  P. Kraulis.  A program to produce both detailed and schematic plots of protein structures , 1991 .

[19]  B. Sykes,et al.  Structure‐activity relationships of chemokines , 1995, Journal of leukocyte biology.

[20]  P. Loetscher,et al.  Lymphocyte‐specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization , 1998, European journal of immunology.

[21]  E. Werner,et al.  Structure and Expression of the Human Small Cytokine B Subfamily Member 11 (SCYB11/formerly SCYB9B, alias I-TAC) Gene Cloned from IFNHuman gamma-Treated Monocytes (THP-1) , 1999 .

[22]  R. Leurs,et al.  Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3). , 1999, The Journal of investigative dermatology.

[23]  E A Merritt,et al.  Raster3D: photorealistic molecular graphics. , 1997, Methods in enzymology.

[24]  H Oschkinat,et al.  Automated NOESY interpretation with ambiguous distance restraints: the refined NMR solution structure of the pleckstrin homology domain from beta-spectrin. , 1997, Journal of molecular biology.

[25]  M. Billeter,et al.  Automated peak picking and peak integration in macromolecular NMR spectra using AUTOPSY. , 1998, Journal of magnetic resonance.

[26]  C. Power,et al.  The chemokine system: novel broad-spectrum therapeutic targets. , 2001, Current opinion in pharmacology.

[27]  Manuel C. Peitsch,et al.  SWISS-MODEL: an automated protein homology-modeling server , 2003, Nucleic Acids Res..

[28]  B. Sykes,et al.  Unmasking ligand binding motifs: identification of a chemokine receptor motif by NMR studies of antagonist peptides. , 2003, Journal of molecular biology.

[29]  Elias Lolis,et al.  Structure, function, and inhibition of chemokines. , 2002, Annual review of pharmacology and toxicology.

[30]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[31]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[32]  J. Baldwin,et al.  An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. , 1997, Journal of molecular biology.

[33]  P. Loetscher,et al.  Structure-Function Relationship between the Human Chemokine Receptor CXCR3 and Its Ligands* , 2003, The Journal of Biological Chemistry.

[34]  J. Farber.  Mig and IP‐10: CXC chemokines that target lymphocytes , 1997, Journal of leukocyte biology.

[35]  P. Loetscher,et al.  Agonistic and antagonistic activities of chemokines , 2001, Journal of leukocyte biology.

[36]  C. Mackay,et al.  Chemokines: immunology's high impact factors , 2001, Nature Immunology.

[37]  J. Anderson,et al.  Chemical synthesis, purification, and folding of C-X-C and C-C chemokines. , 1997, Methods in enzymology.

[38]  Bruce A. Johnson,et al.  NMR View: A computer program for the visualization and analysis of NMR data , 1994, Journal of biomolecular NMR.

[39]  Pierre Plateau,et al.  Exchangeable proton NMR without base-line distorsion, using new strong-pulse sequences , 1982 .

[40]  F. Spertini,et al.  CXCR3 Internalization Following T Cell-Endothelial Cell Contact: Preferential Role of IFN-Inducible T Cell α Chemoattractant (CXCL11)1 , 2001, The Journal of Immunology.

[41]  B. Sykes,et al.  Neutrophil activation by monomeric interleukin-8. , 1994, Science.